Five year outcomes of the American Registry in patients with uncomplicated acute type B aortic dissection treated within the first 30 days with TEVAR vs. conservative management

This document comprises two descriptive studies that suggest biochemical and clinical markers as predictors for adverse outcomes in patients with aortic aneurysms under surveillance.